Loading...
XKRX
214450
Market cap2.74bUSD
Dec 05, Last price  
401,500.00KRW
1D
-2.31%
1Q
-36.27%
Jan 2017
893.81%
IPO
253.43%
Name

PharmaResearch Co Ltd

Chart & Performance

D1W1MN
XKRX:214450 chart
P/E
43.89
P/S
11.54
EPS
9,148.41
Div Yield, %
Shrs. gr., 5y
2.27%
Rev. gr., 5y
33.08%
Revenues
350.12b
+34.14%
37,454,866,93345,953,114,75754,469,757,89164,280,682,05683,871,642,044108,745,921,878154,082,897,894194,758,643,934261,010,910,560350,115,069,000
Net income
92.04b
+20.24%
12,877,827,17213,909,058,67712,955,558,10714,408,301,97416,667,485,00432,774,330,37046,688,655,71040,576,699,24076,551,213,75092,043,313,000
CFO
138.12b
+112.67%
16,022,957,5838,161,008,6038,643,379,0465,203,397,41819,273,230,95132,391,668,89065,297,140,55459,403,807,96664,945,249,410138,121,879,000
Dividend
Dec 27, 2023660 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PharmaResearch Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; Rejuvenex cream, which treats the wound through rapid tissue regeneration; REJURAN HEALER, an intra dermal injection to enhance elasticity, turgidity, and tonicity of skin; Rejuran i and Rejuran s intra dermal or cannula injections; REJURAN moisturizer for daily skin protection; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel; REJURAN healing cream and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. It also provides D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; and CLEVIEL prime plus and contour plus with lidocaine medical devices, as well as CONJURAN medical devices. In addition, the company offers functional foods under the REJULINE, REJUSHINE, and REJULIGHT brands. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Seongnam, South Korea.
IPO date
Jul 24, 2015
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT